Speaker Profile
PhD, Professor of Medicine, U of Colorado
Biography
Dr. Regensteiner is Director of the Ludeman Family Center for Women's Health Research. Her research expertise is in the cardiovascular effects of diabetes with a specific focus on women with type 2 diabetes. Her lab has been funded for over 30 years and her more than 180 publications have influenced the field. She is a Principal Investigator for the National Institutes of Health's Building Interdisciplinary Research Careers in Women's Health (BIRCWH) grant and the Doris Duke Foundation's Fund to Retain Clinical Scientists as well as a Principal Investigator on a NIH RO1 for her research on the cardiovascular consequences of type 2 diabetes. She is on the Advisory Committee for the NIH's Office of Research on Women's Health. She is also an alumna of the Executive Leadership in Academic Medicine Program (ELAM) and is on the steering committee of the national Leaders in Women's Health group.
Talk
Sex and Gender: Focus on Diabetes
Type 2 diabetes confers an increased risk of cardiovascular (CV) disease. CV effects in women may be even more severe than in men. However, little is known about sex and gender differences in CV risks of diabetes. Our research examines sex differences in CV exercise outcomes which may indicate the earliest evidence of heart disease.
Session Abstract – PMWC 2024 Silicon Valley
Track Co-Chairs:
Yoel Sadovsky, UPMC
C. Noel Bairey Merz, Cedars-Sinai Medical Center
The Women's Health Track with a focus on sex differences aims to explore the latest research in this field and highlight the importance of sex-specific analysis in healthcare. The full-day track includes sessions on enhancing women's health research, general sex differences in large studies, pregnancy (Feto-placental) and sex differences, the biology underlying sex differences, and systems and sex differences. The confirmed speakers are leading experts in their respective fields, including cardiovascular medicine, immunology and virology, metabolic disease, Alzheimer's disease, autism, diabetes, exercise, and hypertension. Through this track, attendees will gain valuable insights into the latest research on sex differences in healthcare and the importance of personalized medicine for women.
- PMWC 2024 Award Ceremony
Pioneer Honoree: David Page, MIT
Luminary Honoree: Janine Austin Clayton, NIH
- Keynote: Enhancing Women's Health Research
- Janine Austin Clayton, NIH
- Keynote: Inclusive Research for Better Health: The FDA's Perspective on Sex Differences in Clinical Trials
- Kaveeta Vasisht, FDA
- Keynote: The Chromosomal Basis of Sex Differences in Health and Disease
- David Page, Whitehead Institute
- General Sex Differences in Large Studies
Chair: Karen Reue, UCLA (Sex Differences in Metabolic Disease)
- Franck Mauvis-Jarvis, Tulane University (Sex Differences in Insulin Resistance) - Feto-placental Sex Differences
Chair: Yoel Sadovsky, University of Pittsburgh
- Nima Aghaeepour, Stanford (AI Taxonomy for Reproductive Health)
- Leslie Myatt, OHSU Oregon (Fetal Sex and Pregnancy Outcomes)
- Systems and Sex Differences
Chair: Marcia Stefanick, Stanford (Sex differences in Cancer)
- Judy Regensteiner, University of Colorado (Sex and Gender: Focus on Diabetes)
- Monica Gandhi, UCSF (Sex Differences in HIV) - Cardiovascular Sex Differences
- Martha Gulati, Cedars Sinai - Sex Differences in Alzheimer's Disease
Chair: Marina Sirota, UCSF (Sex Differences in Alzheimer's Disease Using Clinical, Molecular, and Computational Approaches)
- Sarah Banks, UCSD (Sex Differences in Tau Pathology and AD Modifiable Risk)
- Roberta Brinton, University of Arizona (Illuminating Path to Alzheimer's Cure) - Sex Differences and Cognitive-behavioral Function
Chair: Debra Kaysen, Stanford (Gender Effects on Trauma Exposure, PTSD, and Treatment)
